Literature DB >> 1372495

Lymphadenectomy in gastric carcinoma. A prospective and prognostic study.

J Jaehne1, H J Meyer, H Maschek, H Geerlings, E Burns, R Pichlmayr.   

Abstract

In 193 gastric resections for adenocarcinoma, lymphadenectomy was prospectively evaluated to quantify the number of lymph nodes and to identify prognostic factors. Overall, 7112 nodes (median, 36.8 per patient) were resected with 27.2% showing metastases. Most nodes were found in the perigastric region. The histologic type and site of the tumor did not influence the number of invaded nodes, but tumor stage and quality of the resection (curative/palliative) did. By multivariate analysis the tumor stage, curative vs palliative resections, and the number of metastatic lymph nodes in curative resections were independent prognostic factors. Patients with less than six metastatic nodes showed a survival not significantly different from that of patients with normal nodes. These patients may be well treated by surgery alone, but the other patients may require multimodal therapy to improve their prognosis.

Entities:  

Mesh:

Year:  1992        PMID: 1372495     DOI: 10.1001/archsurg.1992.01420030052010

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  33 in total

1.  Lymph node retrieval and examination during the implementation of extended lymph node dissection for gastric cancer in a non-specialized western institution.

Authors:  Marco Catarci; Leonardo Antonio Montemurro; Antonio Di Cintio; Sabrina Ghinassi; Luigi Coppola; Luigi Pinnarelli; Augusto Belardi; Maurizio Koch; Giovanni Battista Grassi
Journal:  Updates Surg       Date:  2010-10

2.  Impact of Combination Criteria of Nodal Counts and Sizes on Preoperative MDCT in Advanced Gastric Cancer.

Authors:  Tsutomu Kawaguchi; Daisuke Ichikawa; Shuhei Komatsu; Toshiyuki Kosuga; Takeshi Kubota; Kazuma Okamoto; Atsushi Shiozaki; Hitoshi Fujiwara; Hirotaka Konishi; Ryo Morimura; Yasutoshi Murayama; Yoshiaki Kuriu; Hisashi Ikoma; Masayoshi Nakanishi; Chouhei Sakakura; Eigo Otsuji
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

3.  Does endoscopic ultrasound staging already allow individual treatment regimens in gastric cancer.

Authors:  Stojan Potrc; Marjan Skalicky; Arpad Ivanecz
Journal:  Wien Klin Wochenschr       Date:  2006       Impact factor: 1.704

Review 4.  Lymphadenectomy for gastric cancer in clinical trials: update.

Authors:  J D Roder; J J Bonenkamp; J Craven; C J van de Velde; M Sasako; K Böttcher; H J Stein
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

5.  Investigation of the recurrence patterns of gastric cancer following a curative resection.

Authors:  Jingyu Deng; Han Liang; Dianchang Wang; Dan Sun; Yi Pan; Yong Liu
Journal:  Surg Today       Date:  2011-01-26       Impact factor: 2.549

6.  PIAS3, an inhibitor of STAT3, has intensively negative association with the survival of gastric cancer.

Authors:  Jingwu Li; Jianzhong Cui; Jinghua Zhang; Yuanting Liu; Longcai Han; Chunliang Jia; Jingyu Deng; Han Liang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

7.  Perspectives of surgery and multimodality treatment in gastric carcinoma.

Authors:  H J Meyer; J Jähne; H Wilke
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

8.  Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study.

Authors:  J R Siewert; K Böttcher; H J Stein; J D Roder
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

9.  Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma.

Authors:  J Jaehne; C Urmacher; H T Thaler; H Friedlander-Klar; C Cordon-Cardo; H J Meyer
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

10.  N stages of the seventh edition of TNM Classification are the most intensive variables for predictions of the overall survival of gastric cancer patients who underwent limited lymphadenectomy.

Authors:  Jingyu Deng; Rupeng Zhang; Yuan Pan; Baogui Wang; Liangliang Wu; Xishan Hao; Han Liang
Journal:  Tumour Biol       Date:  2013-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.